WASHINGTON, DC - SEPTEMBER 30: U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with the company to lower Medicaid drug prices and to sell certain products on the soon-to-launch TrumpRx online platform. (Photo by Win McNamee/Getty Images) Getty Images

Since President Trump issued an executive order in May to have the federal government develop "most-favored nation” price targets for prescription drugs and communicate them to pharmaceutical manufacturers, it’s been difficult to evaluate the model due to a lack of details. About the only thing revealed at the time was that the lowest price would be selected among a set of nations with at least 60% of the United States’ gross domestic product per capita. The most-favored nation deals ann

See Full Page